Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.840
+0.230 (4.99%)
At close: Oct 30, 2025, 4:00 PM EDT
4.840
0.00 (0.00%)
After-hours: Oct 30, 2025, 7:20 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Novel Therapeutics
6.17M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-65.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
6.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-65.98%
Log In
Log In
Log In
Log In
Upgrade